Skip to main content

Table 1 Characteristics of probable IPA in critically ill COPD patients (n = 9)

From: Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study

  Age
(years)
Risk
factors
The length from symptoms to ICU admission (day) APACHE II scores Samples of fungal culture Aspergillus species Serum GM BALF GM The time of antifungal treatment after ICU admission Cause of death
        Day 1 Day 4 Day 7    
1 76 Antibiotics steroid 13 14 ETA none 0.298 0.503 1.321 4.508 Day 2 MOF
2 52 Antibiotics steroid 20 15 ETA A. fumigatus 0.296 0.484 - 0.322 Day 3 RF
3 74 Antibiotics steroid 11 15 ETA
BALF
A. fumigatus &A. flavus 0.626 3.170 - 6.374 Day 2 MOF, SS
4 49 Antibiotics 24 15 ETA none 1.606 1.302 - 1.098 Day 1 MOF
5 87 Antibiotics 17 7 ETA none 0.867 2.499 - 1.510 Day 5 MOF, SS
6 71 Antibiotics steroid 7 10 ETA A. fumigatus 0.562 0.620 - 0.850 Day 6 RF
7 81 Antibiotics steroid 30 15 ETA A. fumigatus &A. versicolor 1.081 2.032 - 2.609 Day 2 MOF
8 59 Antibiotics 60 14 ETA A. fumigatus 1.432 - - 4.057 Day 1 MOF, SS
9 65 Antibiotics steroid 10 18 ETA
BALF
A. fumigatus &A. fiavus 1.072 0.533 - 4.619 Day 1 MOF
  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; BALF, bronchoalveolar lavage fluid; GM, galactomannan, MOF, multiple organ failure; RF, renal failure; SS, septic shock.